Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Mikkel Zöllner AnkarfeldtJanne PetersenJon Trærup AndersenHu LiStephen Paul MotskoThomas FastSimone Møller HedeEspen Jimenez-SolemPublished in: PLoS medicine (2021)
Based on this observational register-based nationwide study with data from Sweden and Denmark, no increased risk of major or minor congenital malformations or stillbirth was associated with exposure to duloxetine during pregnancy.